Chair: Peter Rossing (DNK)
13:00 – 13:05 | Welcome and Introduction | Peter Rossing (DNK) |
13:05 – 13:25 | The Primary Goals of T2D Management – What the Guidelines Recommend | Peter Rossing (DNK) |
13:25 – 13:40 | The Hazards of CKD – Why to Keep a Close Eye on Kidney Function | Sue Pedersen (CAN) |
13:40 – 14:00 | The Tools to Control CKD Progression – The Evidence for Disease-Modifying Therapies | Samy Hadjadj (FRA) |
14:00 – 14:20 | The Clinical Expertise — How to Monitor and Manage CKD | Jose Luis Górriz (ESP) |
14:20 – 14:35 | The Obligation to Act and Audience Q&A | Peter Rossing (DNK) |
14:35 – 14:40 | Closing Remarks and EBAC Evaluation | Peter Rossing (DNK) |
Supported by an independent educational grant from Novo Nordisk A/S
Medscape Global Education
- Monday, 9 September 2024
- 13:00 - 14:40 CEST
- Madrid Hall